Anuradha Kunthur, MBBS

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Associate Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Internal Medicine

Cancer Research Interest

Disease Site Focus: GU, GI
Research Focus Area: Treatment, Diagnosis/ Prognosis
Type of Research: Clinical, Translational
Research Keywords: Prostate cancer
Research Interest Statement: I am a principal investigator for several GU and GI clinical trials and have enrolled patients in clinical trials. I am interested in translational research, and I collaborate with research scientists to design correlative studies. I regularly participate in monthly GI and GU DOC meetings to discuss about the ongoing and new trials to ensure patient enrollment.

“A032201: Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-risk renal cell carcinoma - STRIKE” (NCT06661720)
“S2312, “A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature (CARAVAN)”” (NCT06470243)
“S1802 Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer” (NCT03678025)

Tesfay MZ, Cios A, Ferdous KU, [et al., including Kunthur A]. Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models. Frontiers in immunology. 2025 16:1679665. PMID: 41142777.